dalteparin has been researched along with Central Nervous System Neoplasms in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Central Nervous System Neoplasms: Benign and malignant neoplastic processes that arise from or secondarily involve the brain, spinal cord, or meninges.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Knovich, MA | 1 |
| Lesser, GJ | 1 |
1 review available for dalteparin and Central Nervous System Neoplasms
| Article | Year |
|---|---|
The management of thromboembolic disease in patients with central nervous system malignancies.
Topics: Anticoagulants; Central Nervous System Neoplasms; Dalteparin; Diet; Enoxaparin; Heparin; Humans; Lif | 2004 |